Back to Search
MICHAEL BOYD, M.D.
M.D.
Neurology Physician
NPI: 1891924999IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
036132867(IL)
CMS Specialties
PrimaryNEUROLOGY
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
Prevalence of flexible bronchoscopic removal of foreign bodies in the advanced elderly.
PMID 19401339·Age Ageing·2009
8-other
Interventions for educating children who are at risk of asthma-related emergency department attendance.
PMID 19370563·Cochrane Database Syst Rev·2009
1-meta
The Clinical Antipsychotic Trials of Intervention Effectiveness: what did we learn?
PMID 18207059·Arch Psychiatr Nurs·2008
8-other
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).
PMID 17041859·J Infect Dis·2006
2-rct
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
PMID 16609363·Pharmacogenet Genomics·2006
8-other
Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.
PMID 16897663·J Infect Dis·2006
4-observational
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
PMID 16595641·J Antimicrob Chemother·2006
8-other
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
PMID 16640103·Antivir Ther·2006
2-rct
Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009.
PMID 16268823·HIV Med·2005
3-trial
Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.
PMID 15865224·Antivir Ther·2005
3-trial
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects.
PMID 14526202·J Acquir Immune Defic Syndr·2003
8-other
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide.
PMID 14615475·J Clin Pharmacol·2003
3-trial
Obstacles to prostate cancer screening in African-American men.
PMID 11902015·J Natl Black Nurses Assoc·2001
8-other
Assignment of the MDM2 binding protein gene (MTBP) to human chromosome band 8q24 by in situ hybridization.
PMID 11060448·Cytogenet Cell Genet·2000
8-other
A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2.
PMID 10906133·J Biol Chem·2000
7-preclinical
Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).
PMID 19601993·HIV Med·2010
4-observational
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.
PMID 19649289·PLoS One·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 908 N ELM ST, STE 202
HINSDALE, IL 60521 - Phone
- (630) 856-8640
Quick Facts
- NPI
- 1891924999
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile